4
Changes in Ownership
Aligos Therapeutics, Inc. Filed Acc 0001610717-23-000319
Chief Executive Officer acquired 610,277 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
BLATT LAWRENCE · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-10-25 | Grant or award : show line 1 in the form | +610,277 | $0.76 | $461,858 | 1,847,575 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-10-25 | Grant or award : show line 2 in the form Warrants (Right to Buy) | +305,138 | $0.13 | $38,142 | 305,138 | D |
Loading xslF345X05/form4.xml…